Master the board step 3

Index
Inflammatory bowel disease
(IBD), 197–98, 201, 219
Inflammatory breast cancer, 458
Infliximab, 198
Influenza, 13
vaccine, 13, 286–87
Informed consent, 543
Inguinal hernia, 357
Inhalants, 526
Inhibin A, 420
Initial care, xiv
Inotropic agents, pulmonary
edema, 62–63
Inpatient facility, xiv
Instability, atrial fibrillation, 82
Insulinlike growth factor (IGF),
110
Insulin secretagogues, 91
Insulin therapies, 91–94
Integrase inhibitors, 30–31
Intensive care unit (ICU), 40
aortic dissection, 81
pulmonary edema
management, 62–63
Interferon gamma release assay
(IGRA), 133
Intermitten explosive disorder, 518
Interstitial lung disease (ILD),
119–20, 146
Intestinal atresia, 335, 356
Intra-abdominal abscess, 323–24
Intracranial hemorrhage, 242–44
Intracranial pressure (ICP),
elevated, 315–16
Intrahepatic cholestasis of
pregnancy, 440
Intraluminal obstruction, 382
Intranasal steroids, 41–42
Intraoperative tension
pneumothorax, 332
Intraosseous cannulation, 311
Intrauterine device (IUD), 482
Intrauterine growth restriction
(IUGR), 444–45
Intravenous immunoglobulins,
183–84
Intussusception, 337–38, 398–99
Invasive ductal carcinoma, 458
In vitro fertilization, 484
Iron deficiency, 162
pediatric patient, 407
Irritable bowel syndrome, 203–4
Ischemia, abdominal, 323
Ischemic heart disease, 45–51
diagnosis, 45–47
Isoniazid therapy, 132–33
toxicity, 271
Ivacaftor (VX-770), 386
JAK2 mutation, 178
Jaundice
in newborn, 365–67
obstructive, 324–25
Joint inflammation, 153–55
Juvenile myoclonic epilepsy
(JME), 413
Juvenile polyposis, 205
Juvenile rheumatoid arthritis
(JRA), 140–41
J
K
Kallman’s syndrome, 111
Kaposi’s sarcoma, 305
Kawasaki disease, 405–6
Kayser Fleischer rings, 219
Kernicterus, 367
Kidney imaging, 494
Kleptomania, 518
Klinefelter’s syndrome, 111, 373
KOH preparation, 16–17
Kussmaul’s sign, 78, 80
L
Labor
diabetic patients, 439
normal and abnormal, 448–54
stages, 448
Labyrinthitis, 235
Lactic acidosis, 270
Lactose intolerance, 201
LaPlace law, 73, 81
Large bowel obstruction, 494
Latent tuberculosis, 132–33
Lead poisoning, 407–8
Left heart catheterization, 70, 74
Left-sided murmurs, 67
Leg raises, 67
Leiomyoma, 461–62
Lenalidomide, 175
Leptospirosis, 33
Leukapheresis, 174
Leukemia, 174–78
acute, 174
chronic lymphocytic
leukemia, 176–77
chronic myelogenous
leukemia, 175–76
hairy cell leukemia, 177
myelodysplasia, 175
Leukocyte esterase, urinary tract
infections, 25
Leukocytosis, pelvic inflammatory
disease, 19–20
Levodopa, 229
Lewy body dementia, 231
Lice, 301–2
Lidocaine, 54
Lifesaving therapy, 543
Limited scleroderma, 146–47
Linezolid, 3, 5
Lipid management, 58–59
diabetes, 94
Lipoproteins, 261
Listeria, 240
Lithium, 507, 512
toxicity, 513
Liver disease, in pregnancy, 440
Living will, 545
Lobar pneumonia, 490
Lobular carcinoma in situ (LCIS),
457–58
Loop diuretics, 73
Low ejection fraction, 60
Lucinactant, 359
559